US Stock MarketDetailed Quotes

Akebia Therapeutics (AKBA)

Watchlist
  • 1.340
  • -0.040-2.90%
Close Jan 15 16:00 ET
  • 1.348
  • +0.008+0.61%
Post 19:53 ET
355.59MMarket Cap-16.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics (AKBA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
Operating revenue
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
Cost of revenue
-33.74%9.38M
-41.81%9.92M
-34.30%7.63M
-14.80%63.18M
9.11%20.37M
-21.37%14.16M
-1.37%17.05M
-42.52%11.61M
-13.34%74.15M
644.33%18.67M
Gross profit
112.24%49.38M
97.56%52.55M
136.70%49.71M
-19.48%97M
-30.37%26.13M
-3.20%23.27M
-31.95%26.6M
5.99%21M
-41.78%120.47M
-36.61%37.53M
Operating expense
25.61%44.93M
8.88%38.46M
0.88%36.2M
-11.49%147.42M
11.84%40.44M
-3.07%35.77M
-26.68%35.33M
-20.81%35.88M
-38.72%166.55M
-42.48%36.16M
Selling and administrative expenses
9.72%29.09M
-1.34%26.56M
1.20%25.74M
6.30%106.55M
8.80%27.68M
16.76%26.52M
-0.44%26.92M
1.54%25.44M
-27.68%100.23M
-14.95%25.44M
Research and development costs
76.08%14.94M
44.02%11.01M
0.24%9.75M
-40.31%37.65M
19.47%11.79M
-36.33%8.49M
-62.14%7.65M
-50.57%9.73M
-51.47%63.08M
-69.27%9.87M
Other operating expenses
16.51%896K
17.59%896K
-1.41%701K
-0.53%3.22M
14.25%978K
-11.00%769K
-19.70%762K
25.18%711K
1.95%3.24M
0.47%856K
Operating profit
135.58%4.45M
261.48%14.09M
190.83%13.51M
-9.42%-50.41M
-1,141.27%-14.31M
2.81%-12.51M
4.02%-8.73M
41.63%-14.88M
28.95%-46.08M
137.67%1.37M
Net non-operating interest income expense
28.72%-4.75M
-218.01%-6.83M
-211.05%-7.77M
-201.48%-18.19M
-384.98%-6.88M
-372.41%-6.66M
-30.88%-2.15M
-60.03%-2.5M
61.55%-6.03M
13.33%-1.42M
Non-operating interest expense
-28.72%4.75M
218.01%6.83M
211.05%7.77M
201.48%18.19M
384.98%6.88M
372.41%6.66M
30.88%2.15M
60.03%2.5M
-61.55%6.03M
-13.33%1.42M
Other net income (expense)
266.55%1.45M
-405.76%-7.01M
160.43%368K
-545.60%-811K
-346.20%-1.62M
-311.79%-873K
620.91%2.29M
-446.02%-609K
101.33%182K
183.50%658K
Gain on sale of security
271.03%1.46M
-399.44%-6.98M
220.16%155K
---330K
---1.68M
---856K
--2.33M
---129K
----
----
Special income (charges)
--0
--0
--0
18.44%-575K
--0
--0
--0
-442.45%-575K
95.81%-705K
--0
-Less：Restructuring and merger&acquisition
--0
--0
--0
-67.96%58K
--0
--0
--0
-45.28%58K
-98.86%181K
--0
-Less:Other special charges
----
----
----
-1.34%517K
--0
----
----
--517K
-42.16%524K
--0
Other non- operating income (expenses)
41.18%-10K
28.21%-28K
124.21%213K
-89.40%94K
-91.64%55K
60.47%-17K
-290.00%-39K
-66.31%95K
-71.81%887K
51.61%658K
Income before tax
105.76%1.16M
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
Income tax
615K
0
Net income
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
Net income continuous Operations
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
Minority interest income
Net income attributable to the parent company
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
Basic earnings per share
0
0
133.33%0.03
-17.86%-0.33
-3,197.89%-0.1
-25.00%-0.1
33.33%-0.04
40.00%-0.09
46.15%-0.28
108.07%0.0032
Diluted earnings per share
0
0
133.33%0.03
-17.86%-0.33
-3,207.52%-0.1
-25.00%-0.1
33.33%-0.04
40.00%-0.09
46.15%-0.28
108.05%0.0032
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M-18.49%32.61M-33.46%194.62M0.74%56.2M
Operating revenue 57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M-18.49%32.61M-33.46%194.62M0.74%56.2M
Cost of revenue -33.74%9.38M-41.81%9.92M-34.30%7.63M-14.80%63.18M9.11%20.37M-21.37%14.16M-1.37%17.05M-42.52%11.61M-13.34%74.15M644.33%18.67M
Gross profit 112.24%49.38M97.56%52.55M136.70%49.71M-19.48%97M-30.37%26.13M-3.20%23.27M-31.95%26.6M5.99%21M-41.78%120.47M-36.61%37.53M
Operating expense 25.61%44.93M8.88%38.46M0.88%36.2M-11.49%147.42M11.84%40.44M-3.07%35.77M-26.68%35.33M-20.81%35.88M-38.72%166.55M-42.48%36.16M
Selling and administrative expenses 9.72%29.09M-1.34%26.56M1.20%25.74M6.30%106.55M8.80%27.68M16.76%26.52M-0.44%26.92M1.54%25.44M-27.68%100.23M-14.95%25.44M
Research and development costs 76.08%14.94M44.02%11.01M0.24%9.75M-40.31%37.65M19.47%11.79M-36.33%8.49M-62.14%7.65M-50.57%9.73M-51.47%63.08M-69.27%9.87M
Other operating expenses 16.51%896K17.59%896K-1.41%701K-0.53%3.22M14.25%978K-11.00%769K-19.70%762K25.18%711K1.95%3.24M0.47%856K
Operating profit 135.58%4.45M261.48%14.09M190.83%13.51M-9.42%-50.41M-1,141.27%-14.31M2.81%-12.51M4.02%-8.73M41.63%-14.88M28.95%-46.08M137.67%1.37M
Net non-operating interest income expense 28.72%-4.75M-218.01%-6.83M-211.05%-7.77M-201.48%-18.19M-384.98%-6.88M-372.41%-6.66M-30.88%-2.15M-60.03%-2.5M61.55%-6.03M13.33%-1.42M
Non-operating interest expense -28.72%4.75M218.01%6.83M211.05%7.77M201.48%18.19M384.98%6.88M372.41%6.66M30.88%2.15M60.03%2.5M-61.55%6.03M-13.33%1.42M
Other net income (expense) 266.55%1.45M-405.76%-7.01M160.43%368K-545.60%-811K-346.20%-1.62M-311.79%-873K620.91%2.29M-446.02%-609K101.33%182K183.50%658K
Gain on sale of security 271.03%1.46M-399.44%-6.98M220.16%155K---330K---1.68M---856K--2.33M---129K--------
Special income (charges) --0--0--018.44%-575K--0--0--0-442.45%-575K95.81%-705K--0
-Less：Restructuring and merger&acquisition --0--0--0-67.96%58K--0--0--0-45.28%58K-98.86%181K--0
-Less:Other special charges -------------1.34%517K--0----------517K-42.16%524K--0
Other non- operating income (expenses) 41.18%-10K28.21%-28K124.21%213K-89.40%94K-91.64%55K60.47%-17K-290.00%-39K-66.31%95K-71.81%887K51.61%658K
Income before tax 105.76%1.16M102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K
Income tax 615K0
Net income 102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K
Net income continuous Operations 102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K
Minority interest income
Net income attributable to the parent company 102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K
Basic earnings per share 00133.33%0.03-17.86%-0.33-3,197.89%-0.1-25.00%-0.133.33%-0.0440.00%-0.0946.15%-0.28108.07%0.0032
Diluted earnings per share 00133.33%0.03-17.86%-0.33-3,207.52%-0.1-25.00%-0.133.33%-0.0440.00%-0.0946.15%-0.28108.05%0.0032
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -